Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biolog
Phenotype microarray panels launched for use with mammalian cell lines
October 9th, 2005
Biolog, Inc., announced its first Phenotype MicroArray (PM) cell based assays for use with mammalian cell lines. The mammalian cell capability is added to the expanding list of uses of PM technology for a variety of research applications including drug discovery, functional genomics, and cellular toxicology. PM technology has already been applied for use with a variety of microbial cells important in disease and industrial use, specifically bacteria, yeast and filamentous fungi. The PM mammalian cell panels also have very broad utility. They have already been optimized for use in a wide variety of human cell lines, including liver cell lines (HepG2,...
Source: Managed Care Law Weekly (2005-10-09)
|
